Get App

Co-Partners

Associate Partners

you are here: HomeNewsBusiness
Last Updated : Apr 12, 2019 10:38 AM IST | Source: PTI

Cipla launches Niveoli inhaler in India

Niveoli is used in respiratory inhalation therapy that addresses an unmet need associated with obstructive airway diseases (OAD) such as asthma and chronic obstructive pulmonary disorder (COPD), Cipla said in a BSE filing.

 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Drug major Cipla on Friday announced the launch of its proprietary respiratory inhalation therapy product 'Niveoli' in India.

Niveoli is used in respiratory inhalation therapy that addresses an unmet need associated with obstructive airway diseases (OAD) such as asthma and chronic obstructive pulmonary disorder (COPD), Cipla said in a BSE filing.

Cipla said Niveoli, extra-fine particle beclomethasone-formoterol combination hydrofluoroalkane (HFA) inhaler for adults, targets drug delivery to the small airways.

"We see our market leadership as well as the range and depth of our R&D and manufacturing capabilities in this therapy as a privilege and a responsibility to do more for patients," Cipla Head - India business Nikhil Chopra said.

Shares of Cipla were trading 0.40 per cent higher at Rs 546.55 apiece on BSE.
First Published on Apr 12, 2019 10:35 am
More From
Loading...
Sections
Follow us on
Available On
PCI DSS Compliant